RETA logo

Reata Pharmaceuticals (RETA) Accounts Receivable

RETA Quarterly Accounts Receivable

$22.66 M
0.00%

30 June 2023

All-time High

$30.45 M
RETA quarterly accounts receivable is currently -25.58% below its historical high of $30.45 million
Quarterly Total Assets$502.59 M
RETA quarterly total assets is $502.59 million
Quarterly Current Assets$401.85 M
RETA quarterly total current assets is $401.85 million
Quarterly Total Liabilities$415.30 M
RETA quarterly total liabilities is $415.30 million
Quarterly Current Liabilities$125.09 M
RETA quarterly total current liabilities is $125.09 million

RETA Quarterly Accounts Receivable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RETA Accounts Receivable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years--
5 y5 years--25.6%

RETA Accounts Receivable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time-25.6%

Reata Pharmaceuticals Accounts Receivable History

DateAnnualQuarterly
June 2023
-
$22.66 M(-25.6%)
DateAnnualQuarterly
June 2018
-
$30.45 M(+15.7%)
Mar 2018
-
$26.32 M

FAQ

  • What is Reata Pharmaceuticals quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Reata Pharmaceuticals?

What is Reata Pharmaceuticals quarterly accounts receivable?

The current quarterly accounts receivable of RETA is $22.66 M

What is the all time high quarterly accounts receivable for Reata Pharmaceuticals?

Reata Pharmaceuticals all-time high quarterly accounts receivable is $30.45 M